MAZE

AS OF

Dec 24 closing price

Price

$42.08

Change

-$0.22 (-0.52%)

Capitalization

2.02B

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

MAZE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Maze Therapeutics (MAZE) Ownership - Who owns Maze Therapeutics?

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

MAZE

Capitalization

2.03B

P/E Ratio

191.34

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

384M

Total Cash/Share

7.98

Total Debt

24.2M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

379M

P/B Ratio

5.34

Cash Flow

N/A

Earnings

-2.56

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

48K

Current Ratio

17.70

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-131.96M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-33.02

Shares Held By Institutions

1.14B

Shares Outstanding - Current

48.1M

Total Liabilities

42.6M

Total Volume MTD

N/A

Value

-1

Gain YTD

N/A

View a ticker or compare two or three

Compare

MAZE

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for MAZE

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details